Premium
Inhibitors of mTOR pathway for cancer therapy, moving on from rapalogs to TORKinibs
Author(s) -
Owonikoko Taofeek K.
Publication year - 2015
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.29424
Subject(s) - medicine , pi3k/akt/mtor pathway , cancer , discovery and development of mtor inhibitors , cancer research , oncology , signal transduction , genetics , biology
Advancing cancer treatment through mTOR pathway inhibition has progressed from rapalogs to TORKinibs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom